FDA Updates

Sun care is a hot category that continues to grow. Regardless of seasonality in most parts of the country and many years of flat sales, this category has come back strong in the last few years thanks to new technology, specialized products, and an overall greater consumer awareness of the sun's dangerous effects.

A survey of new Rx, new OTC, new indications, and new generics

New OTC products for coughs and colds are plentiful this year.

A survey of new Rx, new OTC, new indications, and new generics

Exclusive DT survey: Pharmacies are selling more OTC headache medications.

Dietary supplements can cloud a healthcare professional's ability to determine an adverse reaction using the existing Naranjo Questionnaire. That was the point Celtina Reinert, PharmD, pharmacist at Sastun Center of Integrative Health Care, Overland Park, Kansas, tried to enforce at a Tuesday session.

A survey of new Rx, new OTC, new indications, and new generics

Physical and personal trainers recommend supplements and OTC products to their clients without considering possible interactions with other supplements or meds. By becoming an information resource to trainers, pharmacists can take the lead in promoting safe use of these products.

Information on OTC indigestion remedies that pharmacists can use to brief patients

Over-the-counter stomach remedies is one retail segment that has not been soured by skittish consumer spending.

CleviprexTM is the first new IV antihypertensive treatment to be approved by the FDA in 10 years.

A survey of new drugs, new indications, new formulations, new generics, new OTC, and new HBC.

Baby boomer health concerns are just the beginning of what drives vitamin sales.

FDA has approved Xenazine from Prestwick Pharmaceuticals for treatment of chorea in Huntington's disease. It is the first medication to treat any symptom of the disease.

FDA has approved clotrimazole cream USP 1 percent for treatment of skin itching or burning.

Previous medication therapies for diabetes were limited to insulin, sulfonylureas, and metformin. Promising new approaches include DPP-IV inhibitors, GLP-1 analogues, and SGLT-2 inhibitors.

In addition to syringes and insulin vials, products already on the market or in the works include insulin pens, pumps, patches, sprays, and inhaled and oral insulin.

FDA approves clotrimazole cream. The generic will be available in 15g tubes, 30g tubes, and 45g tubes.

A new label design from PharMEDium should make a medication's name and dose easier to read and recognize. The enhanced labeling will be applied first to four patient-controlled, IV pain-management drugs as well as local anesthetics for nerve-block therapy.

A survey of new drugs, new indications, new formulations, new generics, new OTC, and new products.

Current treatments cannot cure cold sores, but they can relieve symptoms. Several new products offer promising results.

New drugs, dosage, indications, generics, and over-the-counter products for sale in pharmacies.

It has been 22 years since the Food and Drug Administration approved a new prescription drug treatment for head lice, but now several new remedies are on the horizon.

Nearly 600 companies exhibited thousands of products at the National Association of Chain Drug Stores Marketplace in San Diego.

New drugs, indications, generics, and over-the-counter products for sale in pharmacies.

Manufacturers are unleashing new oral care over-the-counter products that are innovative.

John Gans tallks candidly about his role at APhA, his departure from APhA and other timely matters affecting the future of pharmacy.

One new program helps independents buy or sell a pharmacy.